Apr 13, 2026 / Transcripts April 2026 public meeting transcript Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Post-Acute Care, Private Plans, Quality, Regional Issues
Apr 10, 2026 / Presentations Preferred networks and pharmacy access in Part D Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests, Regional Issues
Apr 10, 2026 / Presentations Analysis of regional benchmarks and benchmark-plan availability in the Part D PDP market Research Areas: Drugs, Devices, and Tests, Regional Issues
Mar 12, 2026 / Reports March 2026 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans
Mar 12, 2026 / Chapters Executive summary (March 2026 Report) Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans
Mar 12, 2026 / Chapters Chapter 13: The Medicare prescription drug program (Part D): Status report (March 2026 Report) Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests, Medicare Spending and Financing
Feb 25, 2026 / Comment Letters MedPAC comment on CMS’s advance notice of methodological changes for CY 2027 for Medicare Advantage capitation rates and Part C and D payment policies Research Areas: Drugs, Devices, and Tests, Private Plans
Jan 22, 2026 / Comment Letters MedPAC comment on CMS’s proposed rule on policy and technical changes to the Medicare Advantage Program and Medicare Prescription Drug Benefit Program for 2027 Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests, Medicare Spending and Financing, Private Plans
Jan 20, 2026 / Transcripts January 2026 public meeting transcript Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans
Jan 16, 2026 / Presentations The Medicare prescription drug program (Part D): Status report Research Areas: Drugs, Devices, and Tests, Medicare Spending and Financing